Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C.
Armstrong KL, Lee TH, Essex M.
Antimicrob Agents Chemother. 2011 May. 55(5):2146-53. PMID: 21402856
Armstrong KL, Lee TH, Essex M.
Antimicrob Agents Chemother. 2011 May. 55(5):2146-53. PMID: 21402856
Teeravechyan S, Essex M, Lee TH.
AIDS Res Hum Retroviruses. 2010 Apr. 26(4):481-8. PMID: 20377425
Armstrong KL, Lee TH, Essex M.
J Virol. 2009 May. 83(9):4051-9. PMID: 19225005
Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M.
2008 Dec 01. 49(4):410-5. PMID: 19186354
Chigwedere P, Seage GR, Lee TH, Essex M.
AIDS Res Hum Retroviruses. 2008 Jun. 24(6):827-37. PMID: 18544018
Teeravechyan S, Suphaphiphat P, Essex M, Lee TH.
Virology. 2008 Jan 20. 370(2):443-50. PMID: 17936869
Suphaphiphat P, Essex M, Lee TH.
Virology. 2007 Mar 30. 360(1):182-90. PMID: 17101166
Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M.
JAMA. 2006 Aug 16. 296(7):794-805. PMID: 16905785
Da'Dara AA, Lautsch N, Dudek T, Novitsky V, Lee TH, Essex M, Harn DA.
Vaccine. 2006 Jun 12. 24(24):5211-9. PMID: 16675073
Novitsky VA, Gilbert PB, Shea K, McLane MF, Rybak N, Klein I, Thior I, Ndung'u T, Lee TH, Essex ME.
Virology. 2006 May 25. 349(1):142-55. PMID: 16519915
November 2013 -- What starts as a story of death and ignorance becomes a chronicle of discovery and success. To mark its 25th anniversary, the Harvard AIDS Initiative created a short video outlining major accomplishments and the work…
[Fall 2013 Centennial issue] Today, noncommunicable diseases account for two-thirds of all deaths globally. But in low-income nations, three largely preventable infectious diseases—lower respiratory infections, diarrheal infections, and HIV/AIDS—are the leading killers, with malaria, tuberculosis, and neonatal infections…
For immediate release: Monday, October 20, 2008 Boston, MA - More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert…